January 22, 2014 | Shayna Robinson, MSPT, PhD
Can Shoulder Stand Save You Too?
Glutathione: Power Antioxidant
Glutathione is the mother of all antioxidants, the master detoxifier and maestro of immunity. GOOD NEWS, our body produces it. BAD NEWS, when the body becomes overloaded with toxins, it switches off the gene that allows for Glutathione to be created and recycled within the body.
Nearly every person who suffers from chronicfatigue syndrome, heartdisease, cancer, chronicinfections, autoimmune disease, diabetes, autism, Alzheimer‘s disease, Parkinson‘s disease, arthritis, asthma, kidney, liver disease and more is missing the functional ability of the GSTM1 gene.
Post by CoreFitChicago.
Body On Fire
The immune system is supposed to be our greatest defense in defending against pathogens and rebuilding damaged tissue. Without it, your cold would win and your sore back would never heal. Chronic inflammation, brought on by an immune system in overdrive, could lead to illnesses including cancer, heart disease and diabetes.
Inflammation-signaling cells or C-reactive proteins (CRP), is a molecule released by the liver as part of the immune response. These levels should go back to normal levels after defending the body, but instead hang out in the blood. What keeps the battle going? Recurring irritants, such as cigarette smoke, for one. Or, as we now know, carrying too much extra weight, or simply getting older.
The efficiency with which your liver detoxes your blood and circulation are two huge contributing factors to your CRP levels.
Gene Therapy: A Cure For Cancer
At a meeting of The American Society of Hematology on Sunday, researchers from the University of Pennsylvania presented their findings on what very well could be a genetic therapy cure for cancer.
The concept utilizes a disabled form of HIV that genetically alter the patients own T cells to attack malignant B cells. Providing the patient with something better than a drug–a lasting way for the immune system to fight cancer.
University of Pennsylvania researchers developed the experimental treatment that has been tested on 12 patients,
